Recommendations for pneumococcal immunization outside routine childhood immunization programs in Western Europe

Area of Science:

• Public Health
• Infectious Diseases
• Vaccinology

Background:

• Pneumococcal diseases pose a significant global health burden, particularly affecting young children and adults over 50.
• Available vaccines include pneumococcal polysaccharide vaccine (PPV23) and pneumococcal conjugate vaccines (PCV7, PCV10, PCV13).
• Despite existing immunization programs, the burden of pneumococcal disease in adults remains high.

Purpose of the Study:

• To review government recommendations for pneumococcal vaccination outside routine childhood programs in 16 Western European countries as of August 2014.
• To identify variations and complexities in current vaccination guidelines across these nations.

Main Methods:

• Systematic review of national and regional pneumococcal vaccination policies.
• Analysis of recommendations regarding age groups, risk groups, and vaccine types (PPV23, PCV10, PCV13) for adult immunization.

Main Results:

• Pneumococcal immunization recommendations in Western Europe are highly variable.
• Significant differences exist among countries concerning recommended age groups, at-risk populations, and specific vaccines to be administered.
• Recommendations for adult pneumococcal vaccination are complex and not uniform across the studied European countries.

Conclusions:

• Current pneumococcal vaccination recommendations for adults in Western Europe are complex and inconsistent.
• Simplification and improved dissemination of these guidelines are crucial for increasing vaccine uptake.
• Enhanced vaccination strategies can reduce the substantial burden of pneumococcal diseases in adults through direct and herd immunity effects.